title: Stimulation of spleen cells in vitro by nanospheric particles containing antigen.
abstract: Activation of cells, in primary culture, by nanospheres containing antigen has been investigated. Single cell suspensions of spleen cells from primed and nai;ve animals were cocultured with escalating quantities of soluble tetanus toxoid (TT) or TT encapsulated within nanospheres fabricated from poly(lactide-co-glycolide) (PLGA). Concomitantly, spleen cells were also cultured in the presence of 'empty' PLGA nanospheres that contained no TT. Nanospheres loaded with antigen were found to elicit increased proliferation of splenocytes from preimmunised mice in comparison to free antigen during coculture at equivalent doses of immunogen (at low and intermediate doses). Interestingly, cellular proliferation was abolished if B-cells were removed from the splenocyte cultures. Production of IFN-gamma and IL-6 was increased, for formulated as compared to free antigen, in microcultures from both nai;ve and pre-immunised animals. Secretion of IFN-gamma or IL-6 was not observed when primed or nai;ve spleen cells were stimulated with 'empty' polymeric spheres. Some unspecific cytotoxicity was detected if cells were cocultured with high concentrations of PLGA particles, although toxic effects were not seen at concentrations where maximum levels of cytokine secretion and cellular proliferation were recorded. These cell culture data indicate that, at least in this in vitro model, nanoparticulate TT is able to elicit cytokine production that is probably consistent with increased stimulation. This mechanism is likely to be distinct from non-specific effects caused by components of the delivery vehicle itself.
authors.affiliation: DSTL, Porton Down, SP4 0JQ, Salisbury, UK.
authors.forename: J E
authors.initials: JE
authors.lastname: Eyles
authors.forename: V W
authors.initials: VW
authors.lastname: Bramwell
authors.forename: J
authors.initials: J
authors.lastname: Singh
authors.forename: E D
authors.initials: ED
authors.lastname: Williamson
authors.forename: H O
authors.initials: HO
authors.lastname: Alpar
mesh_terms: D000818:Animals; D000941:Antigens / Q000008:administration & dosage* / Q000276:immunology; D002478:Cells, Cultured; D005260:Female; D007371:Interferon-gamma / Q000096:biosynthesis / Q000276:immunology; D015850:Interleukin-6 / Q000096:biosynthesis / Q000276:immunology; D019344:Lactic Acid / Q000008:administration & dosage; D051379:Mice; D008807:Mice, Inbred BALB C; D008863:Microspheres; D036103:Nanotechnology / Q000379:methods*; D011100:Polyglycolic Acid / Q000008:administration & dosage; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers / Q000008:administration & dosage; D013154:Spleen / Q000166:cytology / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D013744:Tetanus Toxin / Q000008:administration & dosage
chemical_list: D000941:Antigens; D015850:Interleukin-6; D011108:Polymers; D013744:Tetanus Toxin; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid; D007371:Interferon-gamma